Characterization of the macrocyclic carbon suboxide factors as potent Na,K-ATPase and SR Ca-ATPase inhibitors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1567, Issue SUPPL., 2002, Pages 213-220

  Kerek, Franz ^a   Stimac, Robert ^b   Apell, Hans Jürgen ^b   Freudenmann, Frank ^a   Moroder, Luis ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Ca ATPase; Endogenous regulatory factor; Enzymatic activity; Macrocyclic carbon suboxide; Na,K ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BIOLOGICAL FACTOR; CARBONYL DERIVATIVE; HYDROXYL GROUP; MACROCYCLIC COMPOUND; MACROCYLCIC CARBON SUBOXIDE FACTOR; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL INTERACTION; DRUG ACTIVITY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; MOLECULAR WEIGHT; PRIORITY JOURNAL; RABBIT; STRUCTURE ANALYSIS;

CALCIUM-TRANSPORTING ATPASES; CARBON COMPOUNDS, INORGANIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; NA(+)-K(+)-EXCHANGING ATPASE; OXIDES; SARCOPLASMIC RETICULUM; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ANIMALIA; DIGITALIS; ORYCTOLAGUS CUNICULUS;

EID: 18744402447     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(02)00609-0     Document Type: Article

References (30)

1. Skou J.C., Esmann M. J. Bioenerg. Biochem. 24:1992;249-261.
2. Rossier B.C., Geering K., Kraehenbuhl J.P. Trends Biochem. Sci. 12:1987;483-487.
3. Lingrel J.B., Kuntzweiler T. J. Biol. Chem. 269:1994;19659-19662.
4. Sweadner K.J. Biochim. Biophys. Acta. 988:1989;185-220.
5. Marín J., Redondo J. Pharmacol. Ther. 84:1999;249-271.
6. Clausen T. Clin. Sci. 95:1998;3-17.
7. Carafoli E., Brini M. Curr. Opin. Chem. Biol. 4:2000;152-161.
8. Inesi G., Chen L., Sumbila C., Lewis D., Kirtle M.E. Biosci. Rep. 15:1995;5929-5936.
9. Fagan M.J., Saier M. Jr. J. Mol. Evol. 38:1994;57-99.
10. Goto A., Yamada K., Yagi N., Yoshioka M., Sugimoto T. Pharmacol. Rev. 44:1992;377-399.
11. Schoner W. Prog. Drug Res. 41:1993;249-291.
12. Hollenberg N.K., Graves S.W. Prog. Drug Res. 46:1996;9-42.
13. Schoner W. Eur. J. Biochem. 269:2002;2440-2448.
14. Kawamura A., Abrell L.M., Maggiali F., Berova N., Nakanishi K., Labutti J., Magil S., Haupert G.T. Jr., Hamlyn J.M. Biochemistry. 40:2001;5835-5844.
15. Szent-Györgyi A. Chemical Physiology of Contraction in Body and Heart Muscle. 1953;86-91 Academic Press, New York.
16. Kerek F. Taniguchi K., Kaya S. Na/K-ATPase and Related ATPases. 2000;763-766 Elsevier, Amsterdam.
17. Kerek F. Hypertens. Res. 23:2000;S33-S38. (Supplement).
18. Kappe T., Ziegler E. Angew. Chem., Int. Ed. Engl. 13:1974;491-558.
19. Jørgensen P.L. Methods Enzymol. 32:1974;277-290.
20. Heilmann C., Brdiczka D., Nickel E., Pette D. Eur. J. Biochem. 81:1977;211-222.
21. Peinelt C., Apell H.-J. Biophys. J. 82:2002;170-181.
22. Schwartz A.K., Nagano M., Nakao M., Lindenmayer G.E., Allen J.C. Methods Pharmacol. 1:1971;361-388.
23. Gatlin C.L., Turecek F. Cole R.B. Electrospray Ionization Mass Spectrometry. 1997;527-565 Wiley, New York.
24. Mathews W.R., DuCharme D.W., Hamlyn J.M., Harris D.W., Mandel F., Clark M.A., Ludens J.H. Hypertension. 17:1991;930-935.
25. Weiler E.W., Khalil-Manesh F., Gonick H.C., Prins B.A., Purdy R.E., Sensharma D.K. Am. J. Hypertens. 12:1999;364-373.
26. Hilton P.J., White R.W., Lord G.A., Garner G.V., Gordon B.D., Hilton M.J., Forni L.G., McKinnon W., Ismail F.M., Keenan M., Jones K., Morden W.E. Lancet. 348:1996;303-305.
27. Tamura M., Harris T.M., Konishi F., Inagami T. Eur. J. Biochem. 211:1993;317-327.
28. Logan-Smith M.J., East J.M., Lee A.G. Biochemistry. 41:2002;2869-2875.
29. Roufogalis B.D., Li Q., vanTran H., Kable E.P.W., Duke C. Drug Dev. Res. 46:1999;235-249.
30. Ursaciuc C., Cotroceanu C., Berindei I., Ioan A. J. Med. Biochem. 4:2000;137-146.